Features of therapy of patients with chronic cerebral ischemia and neurodegenerative diseases during the COVID-19 pandemic
Since first cases of a new coronavirus infection (COVID-19) were detected, as well as World Health Organization named the COVID-19 outbreak as a pandemic, data on the pathogenic potential of the causative agent of SARS-CoV-2 infection has continued to accumulate. In particular, the neurotropic poten...
Saved in:
Main Authors: | E. G. Demyanovskaya, A. S. Vasiliev, V. I. Shmyrev |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Open Systems Publication
2022-03-01
|
Series: | Лечащий Врач |
Subjects: | |
Online Access: | https://journal.lvrach.ru/jour/article/view/899 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
FREQUENCY OF GENES POLYMORPHISM OF PRO-INFLAMMATORY CYTOKINES IN PATIENTS WITH CHRONIC ISCHEMIA OF CEREBRAL ISCHEMIA IN TRANSBAIKALIAN REGION
by: A. S. Knyazeva, et al.
Published: (2014-02-01) -
Microelement composition of oral fluid in patients with chronic cerebral ischemia
by: A. V. Mitronin, et al.
Published: (2023-04-01) -
ALGORITHM OF PSYCHOLOGICAL AND PSYCHOTHERAPEUTIC SUPPORT OF PATIENTS WITH CHRONIC CEREBRAL ISCHEMIA
by: I. V. Khianikiainen, et al.
Published: (2018-06-01) -
Severe diseases of the anterior segment of the eye accompanied by somatic pathology and COVID-19: clinical cases under the pandemic
by: O. I. Lebedev, et al.
Published: (2022-06-01) -
Nonmedical correction of lipid metabolism disorders in patients with chronic cerebral ischemia
by: L. Yu. Dadova, et al.
Published: (2022-01-01)